Sign Up Today and Learn More About Moonwalk Biosciences Stock
Invest in or calculate the value of your shares in Moonwalk Biosciences or other pre-IPO companies through EquityZen's platform.
Moonwalk Biosciences Stock (MOBS)
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Moonwalk Biosciences works on the development of a profiling and engineering technology platform.
About Moonwalk Biosciences Stock
Founded
2022
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Financial Services
Moonwalk Biosciences Press Mentions
Stay in the know about the latest news on Moonwalk Biosciences
Methods and compositions for modifying nucleotide sequences
patents • Feb 08, 2025
Methods and systems for long-range methylation profiling
patents • Feb 08, 2025
Generation and use of epigenetic maps for drug discovery
patents • Feb 08, 2025
Controlled reprogramming of a cell
patents • Feb 08, 2025
The Epigenetics Market to Soar, Expected to Reach USD 66 Billion by 2032 | SNS Insider
einpresswire • Dec 10, 2024
Moonwalk Biosciences Management
Leadership team at Moonwalk Biosciences
CEO
Alex Aravanis
VP Biology & Translational Science
John Liles
Join now and verify your accreditation status to gain access to:
- Moonwalk Biosciences Current Valuation
- Moonwalk Biosciences Stock Price
- Moonwalk Biosciences Management
- Available deals in Moonwalk Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Moonwalk Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Moonwalk Biosciences Revenue and Financials
- Moonwalk Biosciences Highlights
- Moonwalk Biosciences Business Model
- Moonwalk Biosciences Risk Factors
- Moonwalk Biosciences Research Report from SACRA Research
Trading Moonwalk Biosciences Stock
How to invest in Moonwalk Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Moonwalk Biosciences through EquityZen funds. These investments are made available by existing Moonwalk Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Moonwalk Biosciences stock?
Shareholders can sell their Moonwalk Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
